Exercise suppresses DEAF1 to normalize mTORC1 activity and reverse muscle aging

S Sze Mun Choy (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School) K Kah Yong Goh (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School) W Wen Xing Lee (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School) W Weiyi Jiang (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School) Q Qian Gou (Department of Chemistry, School of Chemistry and Chemical Engineering, Chongqing University, No. 55 Daxuecheng South Rd., Shapingba, Chongqing, 401331, P. R. China) P Priya D. Gopal Krishnan (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School) S Shi Chee Ong (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School) K Kenon Chua (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School) N Nathan Harmston (Molecular Biosciences Division, Cardiff School of Biosciences, Cardiff University) H Hong-Wen Tang (Program in Cancer and Stem Cell Biology, Duke-NUS Medical School)

Abstract

Skeletal muscle is essential for movement, respiration, and metabolism, with mTORC1 acting as a key regulator of protein synthesis and degradation. In aging muscle, mTORC1 becomes overactivated, contributing to sarcopenia, though the mechanisms remain unclear. Here, we identify DEAF1, a FOXO-regulated transcription factor, as a key upstream driver of mTORC1 in aged muscle. Elevated Deaf1 expression increases mTOR transcription, leading to heightened mTORC1 activity, impaired proteostasis, and muscle senescence. Remarkably, exercise suppresses Deaf1 expression via FOXO activation, restoring mTORC1 balance and alleviating muscle aging. Conversely, FOXO inhibition or Deaf1 overexpression blocks exercise benefits on muscle health. These findings highlight DEAF1 as a critical link between FOXO and mTORC1 and suggest that targeting the FOXO–DEAF1–mTORC1 axis may offer therapeutic potential to preserve muscle function during aging.

Article Details

Volume / Issue Vol. 122, Issue 48
Published December 02, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

S

Sze Mun Choy

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School

K

Kah Yong Goh

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School

W

Wen Xing Lee

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School

W

Weiyi Jiang

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School

Q

Qian Gou

Department of Chemistry, School of Chemistry and Chemical Engineering, Chongqing University, No. 55 Daxuecheng South Rd., Shapingba, Chongqing, 401331, P. R. China

P

Priya D. Gopal Krishnan

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School

S

Shi Chee Ong

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School

K

Kenon Chua

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School

N

Nathan Harmston

Molecular Biosciences Division, Cardiff School of Biosciences, Cardiff University

H

Hong-Wen Tang

Program in Cancer and Stem Cell Biology, Duke-NUS Medical School